HRZ

HRZ is a venture capital investment firm based in Menlo Park, California, founded in 2022. It operates as a cross-border investor focused on supporting rare Korean technology founders and leveraging global tailwinds to scale their businesses. The firm backs companies across Korea in sectors including consumer products, consumer services, information technology, advanced manufacturing, and other technology-based fields, aiming to connect Korean innovation with international markets.

Christopher Koh

Co-Founder and Managing Partner

9 past transactions

Twelve Labs

Series A in 2024
Twelve Labs offers a platform that empowers businesses and developers to analyze and interpret video content through multiple modalities like visual and auditory data. This enables the creation of intelligent video applications across industries such as technology, media, entertainment, and security.

Nirvanana

Series A in 2024
Nirvanana is a global game development company specializing in online gaming platforms. It creates innovative digital spaces that connect gamers worldwide, fostering immersive, player-driven experiences through its signature character-based, player-to-player system, Zeta.

Makestar

Series D in 2024
Makestar is a global platform connecting Korean pop music enthusiasts with their favorite artists. It facilitates crowdfunding for music projects, enabling fans worldwide to interact with stars, participate in content creation, and support the expansion of Hallyu culture.

Gcore

Series A in 2024
Gcore is a technology company that specializes in cloud, edge, and AI services. It offers a range of products, including a Content Delivery Network (CDN), hosting, storage, streaming platform, DNS, security services, and cloud infrastructure. Gcore's global network of data centers and bare metal servers, along with its user-friendly control panel, enables businesses to enhance website performance, safeguard against cyber threats, and develop machine learning models.

AITRICS

Series B in 2024
AITRICS develops advanced clinical solutions powered by machine learning and evidence-based analysis. Its platform transforms reactive disease care into predictive, preventive, personalized, and participatory care, enabling clinicians to enhance treatment and expand knowledge.

ImpriMed

Series A in 2023
ImpriMed, Inc. is a biotechnology company focused on providing personalized drug response prediction services for veterinary oncology. Established in 2017 and headquartered in Palo Alto, California, with an additional office in Seoul, South Korea, the company specializes in analyzing the drug responses of live cancer cells from pets, particularly in cases of lymphoma. By collecting genetic and cellular information from these cancer cells, ImpriMed develops precision medicine techniques that assist veterinary oncologists in selecting the most effective anticancer treatments for individual pets. This patient-derived database not only enhances treatment decisions for animals but also has the potential to translate insights into human oncology, ultimately aiding in the development of tailored cancer therapies for humans.

Haba24

Venture Round in 2022
Haba24 sells fun, educational, and original toys to develop the senses and learn scientific principles.

Dongnae

Series A in 2022
Dongnae is a real estate platform founded in 2020 and headquartered in Seoul, South Korea. The company aims to transform the rental experience by offering products such as Dongnae FLEX and Dongnae PLUS, which provide renters with financial freedom through low security deposits and flexible lease terms. Dongnae's platform connects users with curated homes and services, facilitating a more efficient search for suitable rental properties based on individual needs. By leveraging technology and expertise from the fields of finance and real estate, Dongnae seeks to enhance the quality of life for renters and change perceptions about renting in Korea.

Contents First

Series B in 2022
Contents First, Inc., based in Seoul, South Korea, is a company specializing in market research consulting, public relations, social media marketing, and translation services. It is best known for operating Tappytoon, a popular digital platform for comics and webnovels that attracts over 8 million readers from more than 190 countries. Launched in 2016, Tappytoon has gained recognition as a leading app in its category, consistently ranking among the top comics apps by gross revenue across multiple countries. The platform offers a diverse library of content, featuring exclusive translations of works from major Korean publishers and original titles produced in collaboration with various creators. Tappytoon provides premium and free content accessible via web and mobile applications, promoting a rich reading experience while supporting the artists and storytellers behind the works.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.